SCHEMBL35211342

SCHEMBL35211342

CC(=O)c1nccc2cn[nH]c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 2/20 0.42
PLK4 O00444 1/20 0.42
CHEK1 O14757 1/20 0.42
AURKA O14965 1/20 0.42
DAPK3 O43293 1/20 0.42
MAP4K4 O95819 1/20 0.42
CSF1R P07333 1/20 0.42
RET P07949 1/20 0.42
FGFR1 P11362 1/20 0.42
PDGFRA P16234 1/20 0.42
LTK P29376 1/20 0.42
KDR P35968 1/20 0.42
MAP2K2 P36507 1/20 0.42
FLT3 P36888 1/20 0.42
CSNK1A1 P48729 1/20 0.42
PRKX P51817 1/20 0.42
CDK5 Q00535 1/20 0.42
MAP2K1 Q02750 1/20 0.42
MST1R Q04912 1/20 0.42
PTK2 Q05397 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3272822 0.84 PLK4 (0.44) ROCK1PLK4CHEK1AURKADAPK3
SCHEMBL29696517 0.84 PLK4 (0.44) ROCK1PLK4CHEK1AURKADAPK3
SCHEMBL29494919 0.83 BTK (0.54) ROCK1PLK4CHEK1AURKADAPK3
SCHEMBL1154955 0.72 NOS1 (0.42) ROCK1PLK4CHEK1AURKADAPK3
SCHEMBL12480129 0.72 MAPT (0.48) ROCK1PLK4CHEK1AURKADAPK3
SCHEMBL20616534 0.70 PLK4 (0.70) ROCK1PLK4CHEK1AURKADAPK3
SCHEMBL18237595 0.69 MAPT (0.42) ROCK1PLK4CHEK1AURKADAPK3
SCHEMBL15416394 0.69 NOS1 (0.41) ROCK1PLK4CHEK1AURKADAPK3
SCHEMBL35211261 0.69 DYRK1A (0.40) ROCK1PLK4CHEK1AURKADAPK3
SCHEMBL12480398 0.68 NOS1 (0.52) ROCK1PLK4CHEK1AURKADAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260125375-A1 SUBSTITUTED 1H-PYRAZOLO-PYRIDINE AND -PYRIMIDINE COMPOUNDS PFIZER INC. (US) 2026-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125375-A1 SUBSTITUTED 1H-PYRAZOLO-PYRIDINE AND -PYRIMIDINE COMPOUNDS CCR1, CCR6, CCRL2 ROCK1 1367/4885PLK4 3113/4885CHEK1 1410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.